Literature DB >> 10981783

Projected number of Australians with glaucoma in 2000 and 2030.

E Rochtchina1, P Mitchell.   

Abstract

Accurate Australian glaucoma prevalence has been provided by two population-based studies: the Blue Mountains Eye Study (BMES) and the Melbourne Visual Impairment Project (MVIP). Both stud es defined glaucoma as the presence of matching optic disc cupp ng with rim thinning and g aucomatous field defects demonstrated on automated perimetry Combining 'definite' and 'probable' rates, the glaucoma prevalence in persons aged 50 and over, age-standardized for the 2000 projected Australian population, was 2.70% (BMES) and 3.13% (MVIP), including rates for 'definite' glaucoma of 2.12% (BMES) and 2.50% (MVIP). The number of Australians aged 50 and over in the year 2000 with g aucoma could be estimated as from 144 000 persons (BMES) to 167 000 persons (MVIP). Assuming similar age-specific rates, the number of Austral ans aged 50 and over in the year 2030 wth glaucoma could be estimated as from 307 000 persons (BMES) to 337 000 persons (MVIP). Ocular hypertens on (OH) was defined as present in subjects without glaucoma wth intraocular pressure (IOP) of more than 21 mmHg, including treated subjects with 'normal' examination IOP The age-standardized OH prevalence was 5.15% (BMES), which projects to 275000 Australians with OH in 2000, increasing to 513000 in 2030.

Entities:  

Mesh:

Year:  2000        PMID: 10981783     DOI: 10.1046/j.1442-9071.2000.00308.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  4 in total

1.  [Arguments for prophylactic therapy of ocular hypertension].

Authors:  J Wahl
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

Review 2.  Treating ocular hypertension to reduce glaucoma risk: when to treat?

Authors:  Eve J Higginbotham
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Implementing collaborative care for glaucoma patients and suspects in Australia.

Authors:  Jessie Huang; Michael P Hennessy; Michael Kalloniatis; Barbara Zangerl
Journal:  Clin Exp Ophthalmol       Date:  2018-03-25       Impact factor: 4.207

4.  Reduced health-related quality of life among Japanese college students with visual impairment.

Authors:  Iguchi Masaki
Journal:  Biopsychosoc Med       Date:  2015-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.